This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
Page 3 of 36

Why AutoZone Isn't Taking the Fast Lane to a Stock Split

By Marc Courtenay

A stock split would reduce the share price below $100 so more retail investors and funds could afford to own AutoZone. But volatility would increase.

06:30AM 06/26/14

A Secure ADT Is Getting Ready to Leave the Doghouse

By Marc Courtenay

In a market where bargains are hard to find this 140-year-old company stands out as it recovers from the doldrums.

06:30AM 06/24/14

Bristol-Myers Squibb Fall From Favor Could Profit Patient Investors

By Marc Courtenay

This once-popular drug stock is shunned and misunderstood by most investors.

06:00AM 06/17/14

Medtronic Is Great but Its Stock Is Too Expensive for Now

By Marc Courtenay

Rumor of a merger pushed the price up. Investors should sit on their hands and wait for the stock to come down.

06:30AM 06/12/14

Allstate Continues Profit Ride With Teen-Monitoring Driving App

By Marc Courtenay

There are many compelling reasons to own this stock starting with the company's business model.

06:30AM 06/10/14

Interpublic Is a Cash-Flow Cow Just Waiting to Be a Takeover Target

By Marc Courtenay

This global advertising powerhouse is a valuable prize for acquisitive competitors and investors who seek takeover targets.

12:36PM 06/05/14

McDonald's Wants to Increase Its Dividend at the Expense of Profits

By Marc Courtenay

The fast-food giant wants to raise its dividend but sell its company-owned stores and take on debt. Is this a recipe for growth?

06:00AM 06/03/14

Xerox Is the Biggest Secret in Value Stocks as It Moves Beyond Copiers

By Marc Courtenay

Xerox beat out HP to manage New York's Medicaid system information technology. Will HP return the favor by buying IBM?

06:30AM 05/30/14

Page 3 of 36

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs